ArticleEuropean journal of endocrinology2020
ENDOCRINOLOGY IN THE TIME OF COVID-19: Diagnosis and management of gestational diabetes mellitus.
Article in European journal of endocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.
- Comparing the screening methods for gestational diabetes mellitus before and during the COVID-19 pandemic: A systematic review.Journal of diabetes investigation · 2024Pooled it
- Incidence of gestational diabetes and inequalities in adverse pregnancy outcomes in England: contemporary, cross sectional observational study of 2.7 million births.BMJ medicine · 2026Article
- Postprandial Hyperglycaemia Screening and Pregnancy Outcomes-Lessons From COVID -19.The Australian & New Zealand journal of obstetrics & gynaecology · 2025Article
- Evaluation of an Alternative Screening Method for Gestational Diabetes Diagnosis During the COVID-19 Pandemic (DIABECOVID STUDY): An Observational Cohort Study.Diagnostics (Basel, Switzerland) · 2025Article
- Navigating Complexities In Randomized Trials: Insights From The EMERGE Trial Amidst Pandemic And Cybersecurity Threat.HRB open research · 2025Article
- Development, validation and clinical utility of a risk prediction model for adverse pregnancy outcomes in women with gestational diabetes: The PeRSonal GDM model.EClinicalMedicine · 2022Article
- Fasting Glucose for the Diagnosis of Gestational Diabetes Mellitus (GDM) during the COVID-19 Pandemic.Nutrients · 2022Article
- Optimising Cardiometabolic Risk Factors in Pregnancy: A Review of Risk Prediction Models Targeting Gestational Diabetes and Hypertensive Disorders.Journal of cardiovascular development and disease · 2022Review
- Association of COVID-19 Lockdown With Gestational Diabetes Mellitus.Frontiers in endocrinology · 2022Article
- Impact of the Gestational Diabetes Diagnostic Criteria during the Pandemic: An Observational Study.Journal of clinical medicine · 2021Article
- COVID-19 and pregnancy: A scoping review on pregnancy characteristics and outcomes.International journal of nursing practice · 2021Article
- COVID-19-related thyroiditis: A novel disease entity?Clinical endocrinology · 2021Review
- Maternal medicine in the COVID era.Best practice & research. Clinical obstetrics & gynaecology · 2021Review
- Screening for Gestational Diabetes Mellitus in Early Pregnancy: What Is the Evidence?Journal of clinical medicine · 2021Review
- Management of gestational diabetes in women with a concurrent severe acute respiratory syndrome coronavirus 2 infection, experience of a single center in Northern Italy.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2021Article
- Utility of Screening Fasting Plasma Glucose and Glycated Hemoglobin to Circumvent the Need for Oral Glucose Tolerance Test in Women with Prior Gestational Diabetes.Advances in therapy · 2021Article
- An Update on Screening Strategies for Gestational Diabetes Mellitus: A Narrative Review.Diabetes, metabolic syndrome and obesity : targets and therapy · 2021Review
- Adherence to Antidiabetic Medications among Women with Gestational Diabetes.Journal of diabetes research · 2021Review
- The Oral Glucose Tolerance Test-Is It Time for a Change?-A Literature Review with an Emphasis on Pregnancy.Journal of clinical medicine · 2020Review
- Testing for gestational diabetes during the COVID-19 pandemic. An evaluation of proposed protocols for the United Kingdom, Canada and Australia.Diabetes research and clinical practice · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 7 institutions in 4 countries.
Funding
Abstract
The COVID-19 pandemic has required rapid transformation and adaptation of healthcare services. Women with gestational diabetes mellitus (GDM) are one of the largest high-risk groups accessing antenatal care. In reformulating the care offered to those with GDM, there is a need to balance the sometimes competing requirement of lowering the risk of direct viral transmission against the potential adverse impact of service changes. We suggest pragmatic options for screening of GDM in a pandemic setting based on blood tests, and risk calculators applied to underlying risk factors. Alternative models for antenatal care provision for women with GDM, including targeting high-risk groups, early lifestyle interventions and remote monitoring are provided. Testing options and their timing for postpartum screening in women who had GDM are also considered. Our suggestions are only applicable in a pandemic scenario, and usual guidelines and care pathways should be re-implemented as soon as possible and appropriate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.